Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.
Physicians need to be aware of the legal and ethical issues raised by genetic information and technology, as evidenced by three court rulings dealing with prenatal testing and a family predisposition to genetic genetically transferred illness.